/
/
/

Norris Medicines Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit16.09
Low (₹)0.00
Lower Circuit14.57
Prev Close15.33
52W High (₹)20.06
Price15.33
52W Low (₹)12.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)15.33 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity-1.45
Price to Book-1.12
Book Value-14.98
EPS (TTM)-0.37
Face Value10.00
ROE (%)0.00

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
CIPLA-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
NORRIS-XNSE
LTP
1W Low
1W High
Market cap (₹)
1760+3.1 (0.18%)
1725.70
1777.40
4,22,427Cr
9220-106 (-1.14%)
8938
9450
2,39,982Cr
4560-100 (-2.15%)
4554
4680.30
1,75,196Cr
1124.3+9.2 (0.83%)
1108
1150.90
1,13,790Cr
2059+26.9 (1.32%)
2008
2086
1,09,143Cr
1325+21.7 (1.67%)
1300.25
1336.65
1,07,746Cr
1231.85+36.75 (3.08%)
1195.65
1250.95
1,01,894Cr
2275-94 (-3.97%)
2269
2425.05
97,264Cr
1658.65-27.45 (-1.63%)
1645
1714.90
96,376Cr
1955.8-4.2 (-0.21%)
1925.85
1990
89,592Cr
15.33+0.08 (0.52%)
14.31
16.60
15Cr

Key Highlights of Norris Medicines Ltd Balance Sheet

Norris Medicines Ltd balance sheet discloses shareholders' funds of ₹9.93Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹9.93Cr, and the reserves and surplus of the company is -₹24.79Cr.

The company has its non-current liabilities with total liabilities of ₹12.91Cr as of 2025-03-31.

The current liabilities are ₹10.15Cr as of 2025-03-31. At the same time, current assets are ₹6.34Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 94522 and tangible assets of ₹5.27Cr, provided in the Norris Medicines Ltd financial statements.